CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of $109.88 billion. The enterprise value is $172.23 billion.
| Market Cap | 109.88B |
| Enterprise Value | 172.23B |
Important Dates
The next estimated earnings date is Wednesday, October 28, 2026, before market open.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | Jul 23, 2026 |
Share Statistics
CVS Health has 1.28 billion shares outstanding. The number of shares has increased by 1.19% in one year.
| Current Share Class | 1.28B |
| Shares Outstanding | 1.28B |
| Shares Change (YoY) | +1.19% |
| Shares Change (QoQ) | +0.63% |
| Owned by Insiders (%) | 0.09% |
| Owned by Institutions (%) | 90.61% |
| Float | 1.28B |
Valuation Ratios
The trailing PE ratio is 22.50 and the forward PE ratio is 10.57. CVS Health's PEG ratio is 1.00.
| PE Ratio | 22.50 |
| Forward PE | 10.57 |
| PS Ratio | 0.27 |
| Forward PS | 0.26 |
| PB Ratio | 1.38 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.34 |
| P/OCF Ratio | 7.43 |
| PEG Ratio | 1.00 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.32, with an EV/FCF ratio of 14.64.
| EV / Earnings | 35.21 |
| EV / Sales | 0.42 |
| EV / EBITDA | 10.32 |
| EV / EBIT | 14.16 |
| EV / FCF | 14.64 |
Financial Position
The company has a current ratio of 0.87, with a Debt / Equity ratio of 0.96.
| Current Ratio | 0.87 |
| Quick Ratio | 0.62 |
| Debt / Equity | 0.96 |
| Debt / EBITDA | 3.87 |
| Debt / FCF | 6.49 |
| Interest Coverage | 3.92 |
Financial Efficiency
Return on equity (ROE) is 6.21% and return on invested capital (ROIC) is 7.17%.
| Return on Equity (ROE) | 6.21% |
| Return on Assets (ROA) | 2.97% |
| Return on Invested Capital (ROIC) | 7.17% |
| Return on Capital Employed (ROCE) | 7.29% |
| Weighted Average Cost of Capital (WACC) | 5.80% |
| Revenue Per Employee | $1.38M |
| Profits Per Employee | $16,300 |
| Employee Count | 300,000 |
| Asset Turnover | 1.61 |
| Inventory Turnover | 20.32 |
Taxes
In the past 12 months, CVS Health has paid $902.00 million in taxes.
| Income Tax | 902.00M |
| Effective Tax Rate | 15.59% |
Stock Price Statistics
The stock price has increased by +12.01% in the last 52 weeks. The beta is 0.58, so CVS Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | +12.01% |
| 50-Day Moving Average | 97.43 |
| 200-Day Moving Average | 87.45 |
| Relative Strength Index (RSI) | 24.14 |
| Average Volume (20 Days) | 6,561,374 |
Short Selling Information
The latest short interest is 18.11 million, so 1.42% of the outstanding shares have been sold short.
| Short Interest | 18.11M |
| Short Previous Month | 18.68M |
| Short % of Shares Out | 1.42% |
| Short % of Float | 1.42% |
| Short Ratio (days to cover) | 2.32 |
Income Statement
In the last 12 months, CVS Health had revenue of $412.65 billion and earned $4.89 billion in profits. Earnings per share was $3.82.
| Revenue | 412.65B |
| Gross Profit | 56.31B |
| Operating Income | 12.16B |
| Pretax Income | 5.79B |
| Net Income | 4.89B |
| EBITDA | 16.68B |
| EBIT | 12.16B |
| Earnings Per Share (EPS) | $3.82 |
Balance Sheet
The company has $13.96 billion in cash and $76.31 billion in debt, with a net cash position of -$62.35 billion or -$48.75 per share.
| Cash & Cash Equivalents | 13.96B |
| Total Debt | 76.31B |
| Net Cash | -62.35B |
| Net Cash Per Share | -$48.75 |
| Equity (Book Value) | 79.90B |
| Book Value Per Share | 62.36 |
| Working Capital | -11.70B |
Cash Flow
In the last 12 months, operating cash flow was $14.78 billion and capital expenditures -$3.02 billion, giving a free cash flow of $11.76 billion.
| Operating Cash Flow | 14.78B |
| Capital Expenditures | -3.02B |
| Depreciation & Amortization | 4.52B |
| Net Borrowing | -5.23B |
| Free Cash Flow | 11.76B |
| FCF Per Share | $9.19 |
Margins
Gross margin is 13.64%, with operating and profit margins of 2.95% and 1.19%.
| Gross Margin | 13.64% |
| Operating Margin | 2.95% |
| Pretax Margin | 1.40% |
| Profit Margin | 1.19% |
| EBITDA Margin | 4.04% |
| EBIT Margin | 2.95% |
| FCF Margin | 2.85% |
Dividends & Yields
This stock pays an annual dividend of $2.66, which amounts to a dividend yield of 3.09%.
| Dividend Per Share | $2.66 |
| Dividend Yield | 3.09% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 69.70% |
| FCF Payout Ratio | 28.93% |
| Buyback Yield | -1.19% |
| Shareholder Yield | 1.91% |
| Earnings Yield | 4.45% |
| FCF Yield | 10.71% |
Analyst Forecast
The average price target for CVS Health is $116.28, which is 35.34% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $116.28 |
| Price Target Difference | 35.34% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 27 |
| Revenue Growth Forecast (3Y) | 3.86% |
| EPS Growth Forecast (3Y) | 12.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 7, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
CVS Health has an Altman Z-Score of 2.43 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.43 |
| Piotroski F-Score | 7 |